IRIS

1.1 Articolo in rivista: [26880] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.901 a 7.920 di 26.880
Titolo Data di pubblicazione Autore(i) File
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Carcinoid Tumors of the Ovary 1-gen-2014 Reed, Ns; Gomez-Garcia, E; Gallardo-Rincon, D; Barrette, B; Baumann, K; Friedlander, M; Kichenadasse, G; Kim, Jw; Lorusso, D; Mirza, Mr; Ray-Coquard, I; Reed, Ns; Gomez-Garcia, E; Gallardo-Rincon, D; Barrette, B; Baumann, K; Friedlander, M; Kichenadasse, G; Kim, Jw
Role of adjuvant chemotherapy in early-stage endometrioid and clear-cell ovarian cancer 1-gen-2017 Lorusso, D; Pignata, S.
Persistent dyspepsia after laparoscopic cholecystectomy. The influence of psychological factors 1-gen-2003 Lorusso, D; Porcelli, P; Pezzolla, F; Lantone, G; Zivoli, G; Guerra, V; Misciagna, G; Demma, I
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial 1-gen-2011 Pignata, Sandro; Scambia, Giovanni; Ferrandina, Gabriella; Savarese, Antonella; Sorio, Roberto; Breda, Enrico; Gebbia, Vittorio; Musso, Pietro; Frigerio, Luigi; Del Medico, Pietro; Lombardi Alessandra, Vernaglia; Febbraro, Antonio; Scollo, Paolo; Ferro, Antonella; Tamberi, Stefano; Brandes, Alba; Ravaioli, Alberto; Valerio Maria, Rosaria; Aitini, Enrico; Natale, Donato; Scaltriti, Laura; Greggi, Stefano; Pisano, Carmela; Lorusso, D; Salutari, Vanda; Legge, Francesco; Di Maio, Massimo; Morabito, Alessandro; Gallo, Ciro; Perrone, Francesco
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) 1-gen-2021 Gaillard, S; Oaknin, A; Ray-Coquard, I; Vergote, I; Scambia, G; Colombo, N; Fernandez, C; Alfaro, V; Kahatt, C; Nieto, A; Zeaiter, A; Aracil, M; Vidal, L; Pardo-Burdalo, B; Papai, Z; Kristeleit, R; O'Malley, Dm; Benjamin, I; Pautier, P; Lorusso, D
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years 1-gen-2022 Falcone, R; Lombardi, P; Filetti, M; Duranti, S; Pietragalla, A; Fabi, A; Lorusso, D; Altamura, V; Paroni Sterbini, F; Scambia, G; Daniele, G
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 1-gen-2019 Gori, S; Barberis, M; Bella, Ma; Buttitta, F; Capoluongo, E; Carrera, P; Colombo, N; Cortesi, L; Genuardi, M; Gion, M; Guarneri, V; Incorvaia, L; La Verde, N; Lorusso, D; Marchetti, A; Marchetti, P; Normanno, N; Pasini, B; Pensabene, M; Pignata, S; Radice, P; Ricevuto, E; Sapino, A; Tagliaferri, P; Tassone, P; Trevisiol, C; Truini, M; Varesco, L; Russo, A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working, Group.
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience 1-gen-2011 Mangili, G.; Sigismondi, C.; Lorusso, D; Cormio, G.; Scollo, P.; Vigano, R.; Gamucci, T.; Candiani, M.; Pignata, S.
Sentinel-lymph-node mapping in endometrial cancer 1-gen-2017 Bogani, G; Ditto, A; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F.
PARPi related toxicities: do we need more appropriate instruments to evaluate it? 1-gen-2018 Lorusso, D; Pignata, S
Newly diagnosed ovarian cancer: Which first-line treatment? 1-gen-2020 Lorusso, D; Ceni, V; Daniele, G; Salutari, V; Pietragalla, A; Muratore, M; Nero, C; Ciccarone, F; Scambia, G
Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery 1-gen-2017 Ditto, A; Bogani, G; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Indini, A; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F.
Phase II exploratory study of brostallicin in patients with ovarian cancer resistant/refractory to platinum-based chemotherapy 1-gen-2008 Lorusso, D; Zanaboni, F.; Scalone, S.; Secomandi, R.; Ferrandina, G.; Scambia, G.; Jannuzzo, M. G.; Petroccione, A.; Comis, S.; Raspagliesi, F.
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience. 1-gen-2017 Bogani, G; Tagliabue, E; Signorelli, M; Chiappa, V; Carcangiu, Ml; Paolini, B; Casarin, J; Scaffa, C; Gennaro, M; Martinelli, F; Borghi, C; Ditto, A; Lorusso, D; Raspagliesi, F.
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer 1-gen-2017 Marth, C; Vergote, I; Scambia, G; Oberaigner, W; Clamp, A; Berger, R; Kurzeder, C; Colombo, N; Vuylsteke, P; Lorusso, D; Hall, M; Renard, V; Pignata, S; Kristeleit, R; Altintas, S; Rustin, G; Wenham, Rm; Mirza, Mr; Fong, Pc; Oza, A; Monk, Bj; Ma, H; Vogl FD, ; Bach, Ba.
High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies 1-gen-2014 Lorusso, D; Ratti, M; Ditto, A; Raspagliesi, F
Review role of topotecan in gynaecological cancers: Current indications and perspectives 1-gen-2010 Lorusso, D; Pietragalla, Antonella; Mainenti, Sara; Masciullo, Valeria; Di Vagno, Giovanni; Scambia, Giovanni
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO 1-gen-2011 Harter, Philipp; Sehouli, Jalid; Reuss, Alexander; Hasenburg, Annette; Scambia, Giovanni; Cibula, David; Mahner, Sven; Vergote, Ignace; Reinthaller, Alexander; Burges, Alexander; Hanker, Lars; Poelcher, Martin; Kurzeder, Christian; Canzler, Ulrich; Petry Karl, Ulrich; Obermair, Andreas; Petru, Edgar; Schmalfeldt, Barbara; Lorusso, D; du Bois, Andreas; Harter, Philipp; Sehouli, Jalid; Reuss, Alexander; Hasenburg, Annette; Scambia, Giovanni; Cibula, David; Mahner, Sven; Vergote, Ignace; Reinthaller, Alexander; Burges, Alexander; Hanker, Lars; Poelcher, Martin; Kurzeder, Christian; Canzler, Ulrich; Petry Karl, Ulrich; Obermair, Andreas; Petru, Edgar; Schmalfeldt, Barbara; Lorusso, D; du Bois, Andreas
Rucaparib: a new treatment option for ovarian cancer 1-gen-2018 Sabatucci, I; Maltese, G; Lepori, S; Tripodi, E; Bogani, G; Lorusso, D
Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas 1-gen-2017 Ferrero, S; Leone Roberti Maggiore, U; Aiello, N; Barra, F; Ditto, A; Bogani, G; Raspagliesi, F; Lorusso, D
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.901 a 7.920 di 26.880
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26880
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro723
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA456
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269084
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS227
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE182
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19415
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19160
  • ita408
  • spa13
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24627
  • reserved1362
  • open891